CHEMICAL, CLINICAL, AND IMMUNOLOGICAL STUDIES ON THE PRODUCTS OF HUMAN PLASMA FRACTIONATION XXX. THE USE OF SALT-POOR CONCENTRATED HUMAN SERUM ALBUMIN SOLUTION IN THE TREATMENT OF CHRONIC BRIGHT'S DISEASE 123

George W. Thorn, S. Howard Armstrong, Virginia Davenport, L. M. Woodruff, Frank H. Tyler

Journal of Clinical Investigation · 1945 · 104 citations · 44 references

DOIFull text

Open access

Concepts

Abstract

Much of the disability induced by chronic Bright's disease, particularly during the nephrotic stage, is attributable to thte coexistent disturbances in pro- tein metabolism. The latter may be characterized as follows: 1, proteinuria; 2, hypoalbuminemia; and 3, depletion of tissue protein stores. During the past few years, numerous attempts have been made to correct the hypoalbuminemia, depletion of body protein stores, and attendant edema in patients with nephrotic syndromes by administering human plasma intravenously (1, 2, 3). This form of therapy obviously had as its objectives the use of protein solution as a diuretic agent by virtue of its high colloid osmotic pressure, the restoration of serum albumin level, and the replenishment of body protein stores. The last two objectives were rarely, if ever, attained because of the limited quantity and high cost of human

References

44